Lymphomatoid granulomatosis with involvement of the hard palate: a case report.
Department of Oral and Maxillofacial Surgery, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.
Rabie M
RM
Shanti
Carlos A
CA
Torres-Cabala
Elaine S
ES
Jaffe
Wyndham H
WH
Wilson
Jaime S
JS
Brahim
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000821:virology*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000473:pathology*; D008230:Lymphomatoid Granulomatosis / Q000188:drug therapy* / Q000821:virology; D010157:Palatal Neoplasms / Q000188:drug therapy / Q000556:secondary* / Q000821:virology; D021362:Palate, Hard / Q000473:pathology*; D011241:Prednisone / Q000008:administration & dosage; D000069283:Rituximab; D014750:Vincristine / Q000008:administration & dosage
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000998:Antiviral Agents; D016898:Interferon-alpha; D000069283:Rituximab; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone